FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “DECYST”, which is offered here for Pharmaceuticals for the treatment of cystic fibrosis, rhinosinusitis, chronic obstructive pulmonary disease, paroxysmal nocturnal hemoglobinuria, familial hypercholesterolemia, tay-sachs disease, viral diseases, neoplastic diseases, hereditary myeloperoxidase deficiency, congenital insulin resistance, nephrogenic diabetes insipidus, hemochromatosis, gitelman's syndrome, a1-antitryspin deficiency, cystinuria and all other disorders associated with retention of misfolded proteins in the endoplasmic reticulum;.
Its status is currently believed to be active. Its class is unavailable. “DECYST” is believed to be currently owned by “Panacea Pharmaceuticals”.
| Owner: |
PANACEA PHARMACEUTICALS
Owner Details |
|---|---|
| Description: |
Pharmaceuticals for the treatment of Cystic Fibrosis, Rhinosinusitis, Chronic Obstructive Pulmonary Disease, Paroxysmal Nocturnal Hemoglobinuria, Familial Hypercholesterolemia, Tay-Sachs Disease, viral diseases, neoplastic diseases, Hereditary Myeloperoxidase Deficiency, Congenital Insulin Resistance, Nephrogenic Diabetes Insipidus, Hemochromatosis, Gitelman's Syndrome, a1-antitryspin Deficiency, Cystinuria and all other disorders associated with retention of misfolded proteins in the endoplasmic reticulum;
|
| Categories: | PHARMACEUTICALS TREATMENT |